Table 1.
Experimental set up | Protein of interest | Disease | Transferring species | Cell line |
---|---|---|---|---|
Membrane barrier | Dipeptide repeat proteins from C9orf72 hexanucleotide repeat expansions | ALS | N.C. | NSC-34 [51] |
SOD1 | ALS | N.C. | Neuro 2 A [45] | |
Application onto acceptor culture | Tau | Alzheimer's | N.C [80]., Fibrils [81] |
HEK293 [80], Primary neurons [81] |
Huntingtin (Q19 and Q103) | Huntington's | N.C. | HEK donors and SH-SY5Y acceptors [82] | |
α-Synuclein | Parkinson's | Monomers, oligomers and fibrils [83] High and low molecular weight oligomers [84] |
SH-SY5Y donors and COS-7 acceptors [83] Differentiated and undifferentiated SH-SY5Y [84] |
|
SOD1 | ALS | N.C [45]. | Neuro 2 A [45] | |
TDP-43 | ALS | N.C. | HEK293 [27], [74] | |
Exosome isolation | Yeast prion Sup35 (NM domain) | N.A. | Multimers [85] N.C [86]. |
Neuro2A [85], [86] |
SOD1 | ALS | N.C. | NSC-34 [66] | |
Complementary protein assay model | Tau | Alzheimer's | N.C. | HEK293T [87] |
TDP-43 | ALS | Dimers, oligomers | HEK293 [75] |